PRENYL CAPROATE
General Information
Mainterm | PRENYL CAPROATE |
Doc Type | EAF |
CAS Reg.No.(or other ID) | 76649-22-4 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 173534 |
IUPAC Name | 3-methylbut-2-enyl hexanoate |
InChI | InChI=1S/C11H20O2/c1-4-5-6-7-11(12)13-9-8-10(2)3/h8H,4-7,9H2,1-3H3 |
InChI Key | MUVXQQVJNUBWPF-UHFFFAOYSA-N |
Canonical SMILES | CCCCCC(=O)OCC=C(C)C |
Molecular Formula | C11H20O2 |
Wikipedia | prenyl caproate |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 184.279 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 7 |
Complexity | 167.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A D A C g g A I C C A A A B A C I A i D S C A A A A A A A A A A A C A E A A A A A B B I A I Q A C E A A E A A A A I A G I S A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 26.3 |
Monoisotopic Mass | 184.146 |
Exact Mass | 184.146 |
XLogP3 | None |
XLogP3-AA | 3.5 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 13 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9371 |
Human Intestinal Absorption | HIA+ | 0.9969 |
Caco-2 Permeability | Caco2+ | 0.6980 |
P-glycoprotein Substrate | Non-substrate | 0.5776 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7317 |
Non-inhibitor | 0.7205 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8692 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5488 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8819 |
CYP450 2D6 Substrate | Non-substrate | 0.8814 |
CYP450 3A4 Substrate | Substrate | 0.5298 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6823 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9105 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9284 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8736 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9267 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6530 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8931 |
Non-inhibitor | 0.8462 | |
AMES Toxicity | Non AMES toxic | 0.9281 |
Carcinogens | Carcinogens | 0.5692 |
Fish Toxicity | High FHMT | 0.9567 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9993 |
Honey Bee Toxicity | High HBT | 0.8519 |
Biodegradation | Ready biodegradable | 0.9698 |
Acute Oral Toxicity | IV | 0.4928 |
Carcinogenicity (Three-class) | Non-required | 0.5336 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.8244 | LogS |
Caco-2 Permeability | 1.1862 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.4292 | LD50, mol/kg |
Fish Toxicity | 0.5565 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.0919 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty acid esters |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty acid esters |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty acid ester - Carboxylic acid ester - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty acid esters. These are carboxylic ester derivatives of a fatty acid. |
From ClassyFire